The Role of Chemotherapy in Upper Tract Urothelial Carcinoma

Por O'Donnell, Peter H., Stadler, Walter M.
Publicado em 2009

Cancer Pharmacoethnicity: Ethnic Differences in Susceptibility to the Effects of Chemotherapy

Por O’Donnell, Peter H., Dolan, M. Eileen
Publicado em 2009

Pharmacogenomics in Early Phase Oncology Clinical Trials: Is There a Sweet Spot in Phase II?

Por O'Donnell, Peter H., Stadler, Walter M.
Publicado em 2012

The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone

Por O’Donnell, Peter H., Danahey, Keith, Ratain, Mark J.
Publicado no Clin Pharmacol Ther (2016)

Clinicopathologic Features of Late Onset Veno-Occlusive Disease/Sinusoidal Obstructive Syndrome After High Dose Busulfan and Hematopoietic Cell Transplantation

Por Pai, Rish K., van Besien, Koen, Hart, John, Artz, Andrew S., O’Donnell, Peter H.
Publicado no Leuk Lymphoma (2012)

University of Chicago Center for Personalized Therapeutics: research, education and implementation science

Por Dolan, M Eileen, Maitland, Michael L, O’Donnell, Peter H, Nakamura, Yusuke, Cox, Nancy J, Ratain, Mark J
Publicado em 2013

Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant

Por Petri, Camille R., O’Donnell, Peter H., Cao, Hongyuan, Artz, Andrew S., Stock, Wendy, Wickrema, Amittha, Hard, Marjie, van Besien, Koen
Publicado no Leuk Lymphoma (2014)

The 1200 Patients Project: Creating A New Medical Model System for Clinical Implementation of Pharmacogenomics

Por O’Donnell, Peter H., Bush, Angela, Spitz, Jared, Danahey, Keith, Saner, Don, Das, Soma, Cox, Nancy J., Ratain, Mark J.
Publicado no Clin Pharmacol Ther (2012)

Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants

Por O'Donnell, Peter H., Gamazon, Eric, Zhang, Wei, Stark, Amy L., Kistner-Griffin, Emily O., Huang, R. Stephanie, Dolan, M. Eileen
Publicado em 2010

A Phase I Study of Continuous Infusion Cilengitide in Patients with Solid Tumors

Por O’Donnell, Peter H., Undevia, Samir D., Stadler, Walter M., Karrison, Theodore M., Nicholas, M. Kelly, Janisch, Linda, Ratain, Mark J.
Publicado em 2010

Population Differences in the Rate of Proliferation of International HapMap Cell Lines

Por Stark, Amy L., Zhang, Wei, Zhou, Tong, O'Donnell, Peter H., Beiswanger, Christine M., Huang, R. Stephanie, Cox, Nancy J., Dolan, M. Eileen
Publicado em 2010

Comprehensive Evaluation of the Contribution of X Chromosome Genes to Platinum Sensitivity

Por Gamazon, Eric R., Im, Hae Kyung, O’Donnell, Peter H., Ziliak, Dana, Stark, Amy L., Cox, Nancy J., Dolan, M. Eileen, Huang, Rong Stephanie
Publicado em 2011

A randomized phase II study of pazopanib in hormone sensitive prostate cancer: a University of Chicago Phase II Consortium/ Department of Defense Prostate Cancer Clinical Trials Co...

Por Ward, James E., Karrison, Theodore, Chatta, Gurkamal, Hussain, Maha, Shevrin, Daniel, Szmulewitz, Russell Z., O’Donnell, Peter H., Stadler, Walter M., Posadas, Edwin M.
Publicado no Prostate Cancer Prostatic Dis (2011)

BK Virus Infection is Associated with Hematuria and Renal Impairment in Recipients of Allogeneic Hematopoetic Stem Cell Transplants

Por O’Donnell, Peter H., Swanson, Kate, Josephson, Michelle A., Artz, Andrew S., Parsad, Sandeep D., Ramaprasad, Charulata, Pursell, Kenneth, Rich, Elizabeth, Stock, Wendy, van Besien, Koen
Publicado em 2009

Genome-wide Meta-analysis Identifies Variants Associated with Platinating Agent Susceptibility Across Populations

Por Wheeler, Heather E., Gamazon, Eric R., Stark, Amy L., O’Donnell, Peter H., Gorsic, Lidija K., Huang, R. Stephanie, Cox, Nancy J., Dolan, M. Eileen
Publicado em 2011

Dynamic Contrast Enhanced-Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma

Por Sweis, Randy F., Medved, Milica, Towey, Shannon, Karczmar, Gregory S., Oto, Aytekin, Szmulewitz, Russell Z., O’Donnell, Peter H., Fishkin, Paul, Karrison, Theodore, Stadler, Walter M.
Publicado no Clin Genitourin Cancer (2016)

Saracatinib as a Metastasis Inhibitor in Metastatic Castration-Resistant Prostate Cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Con...

Por Posadas, Edwin M., Ahmed, Rafi S., Karrison, Theodore, Szmulewitz, Russell Z., O’Donnell, Peter H., Wade, James L., Shen, James, Gururajan, Murali, Sievert, Margarit, Stadler, Walter M.
Publicado no Prostate (2015)

Establishment of CYP2D6 Reference Samples by Multiple Validated Genotyping Platforms

Por Fang, Hua, Liu, Xiao, Ramírez, Jacqueline, Choudhury, Noura, Kubo, Michiaki, Im, Hae Kyung, Konkashbaev, Anuar, Cox, Nancy J., Ratain, Mark J., Nakamura, Yusuke, O’Donnell, Peter H.
Publicado no Pharmacogenomics J (2014)

Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation

Por van Besien, Koen, Stock, Wendy, Rich, Elizabeth, Odenike, Olatoyosi, Godley, Lucy A., O’Donnell, Peter H., Kline, Justin, Nguyen, Vu, del Cerro, Paula, Larson, Richard A., Artz, Andrew S.
Publicado em 2011

Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs

Por Kaufman, Amy L., Spitz, Jared, Jacobs, Michael, Sorrentino, Matthew, Yuen, Shennin, Danahey, Keith, Saner, Donald, Klein, Teri E., Altman, Russ B., Ratain, Mark J., O’Donnell, Peter H.
Publicado no Mayo Clin Proc (2015)